{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:51:28Z","timestamp":1774655488014,"version":"3.50.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12010-017-2631-0","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T05:11:14Z","timestamp":1508217074000},"page":"1390-1403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["RETRACTED ARTICLE: Nephrotoxicity Induced by Cisplatin Intake in Experimental Rats and Therapeutic Approach of Using Mesenchymal Stem Cells and Spironolactone"],"prefix":"10.1007","volume":"184","author":[{"given":"Mohamed M.","family":"Elseweidy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervat E.","family":"Askar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar E.","family":"Elswefy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"issue":"1","key":"2631_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152007779314044","volume":"7","author":"V Cepeda","year":"2007","unstructured":"Cepeda, V., Fuertes, M. A., Castilla, J., Alonso, C., Quevedo, C., & Perez, J. M. (2007). Biochemical mechanisms of cisplatin cytotoxicity. Anti-Cancer Agents in Medicinal Chemistry, 7(1), 3\u201318.","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"issue":"1","key":"2631_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pharmthera.2012.07.003","volume":"136","author":"SM Sancho-Martinez","year":"2012","unstructured":"Sancho-Martinez, S. M., Prieto-Garcia, L., Prieto, M., Lopez-Novoa, J. M., & Lopez-Hernandez, F. J. (2012). Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacology & Therapeutics, 136(1), 35\u201355.","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"2631_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s12010-013-0561-z","volume":"172","author":"J-l Zhao","year":"2014","unstructured":"Zhao, J.-l., Zhao, J., & Jiao, H.-j. (2014). Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells. Applied Biochemistry and Biotechnology, 172(2), 784\u2013791.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"1","key":"2631_CR4","doi-asserted-by":"publisher","first-page":"F7","DOI":"10.1152\/ajprenal.00451.2003","volume":"287","author":"Y Liu","year":"2004","unstructured":"Liu, Y. (2004). Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. American journal of physiology Renal Physiology, 287(1), F7\u201316.","journal-title":"American journal of physiology Renal Physiology"},{"issue":"3\u20134","key":"2631_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s004670000461","volume":"15","author":"AA Eddy","year":"2000","unstructured":"Eddy, A. A. (2000). Molecular basis of renal fibrosis. Pediatric Nephrology, 15(3\u20134), 290\u2013301.","journal-title":"Pediatric Nephrology"},{"issue":"5","key":"2631_CR6","doi-asserted-by":"publisher","first-page":"F861","DOI":"10.1152\/ajprenal.00362.2001","volume":"283","author":"S Klahr","year":"2002","unstructured":"Klahr, S., & Morrissey, J. (2002). Obstructive nephropathy and renal fibrosis. American Journal of Physiology Renal Physiology, 283(5), F861\u2013F875.","journal-title":"American Journal of Physiology Renal Physiology"},{"issue":"12","key":"2631_CR7","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1681\/ASN.V7122495","volume":"7","author":"AA Eddy","year":"1996","unstructured":"Eddy, A. A. (1996). Molecular insights into renal interstitial fibrosis. Journal of the American Society of Nephrology : JASN, 7(12), 2495\u20132508.","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"4","key":"2631_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1046\/j.1523-1755.2000.00997.x","volume":"57","author":"F Strutz","year":"2000","unstructured":"Strutz, F., Zeisberg, M., Hemmerlein, B., Sattler, B., Hummel, K., Becker, V., & Muller, G. A. (2000). Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney International, 57(4), 1521\u20131538.","journal-title":"Kidney International"},{"issue":"1","key":"2631_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1357-2725(96)00119-7","volume":"29","author":"AM el Nahas","year":"1997","unstructured":"el Nahas, A. M., Muchaneta-Kubara, E. C., Essawy, M., & Soylemezoglu, O. (1997). Renal fibrosis: insights into pathogenesis and treatment. The International Journal of Biochemistry & Cell Biology, 29(1), 55\u201362.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"11","key":"2631_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneph.2010.120","volume":"6","author":"P Boor","year":"2010","unstructured":"Boor, P., Ostendorf, T., & Floege, J. (2010). Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nature Reviews. Nephrology, 6(11), 643\u2013656.","journal-title":"Nature Reviews. Nephrology"},{"issue":"5","key":"2631_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrneph.2014.31","volume":"10","author":"AE Decleves","year":"2014","unstructured":"Decleves, A. E., & Sharma, K. (2014). Novel targets of antifibrotic and anti-inflammatory treatment in CKD. Nature Reviews. Nephrology, 10(5), 257\u2013267.","journal-title":"Nature Reviews. Nephrology"},{"issue":"14","key":"2631_CR12","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.1073\/pnas.120055097","volume":"97","author":"FN Ziyadeh","year":"2000","unstructured":"Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-De La Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000). Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice. Proceedings of the National Academy of Sciences of the United States of America, 97(14), 8015\u20138020.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"2631_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0006-291X(02)02708-0","volume":"300","author":"S Chen","year":"2003","unstructured":"Chen, S., Iglesias-de la Cruz, M. C., Jim, B., Hong, S. W., Isono, M., & Ziyadeh, F. N. (2003). Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db\/db mice. Biochemical and Biophysical Research Communications, 300(1), 16\u201322.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"2631_CR14","doi-asserted-by":"publisher","first-page":"F199","DOI":"10.1152\/ajprenal.00665.2012","volume":"305","author":"Q Guan","year":"2013","unstructured":"Guan, Q., Li, S., Gao, S., Chen, H., Nguan, C. Y., & Du, C. (2013). Reduction of chronic rejection of renal allografts by anti-transforming growth factor-beta antibody therapy in a rat model. American journal of physiology Renal Physiology, 305(2), F199\u2013F207.","journal-title":"American journal of physiology Renal Physiology"},{"issue":"24","key":"2631_CR15","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1016\/j.bmcl.2013.09.100","volume":"23","author":"SJ Williams","year":"2013","unstructured":"Williams, S. J., Zammit, S. C., Cox, A. J., Shackleford, D. M., Morizzi, J., Zhang, Y., Powell, A. K., Gilbert, R. E., Krum, H., & Kelly, D. J. (2013). 3\u2032,4\u2032-Bis-difluoromethoxycinnamoylanthranilate (FT061): an orally-active antifibrotic agent that reduces albuminuria in a rat model of progressive diabetic nephropathy. Bioorganic & Medicinal Chemistry Letters, 23(24), 6868\u20136873.","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"6","key":"2631_CR16","doi-asserted-by":"publisher","first-page":"F1138","DOI":"10.1152\/ajprenal.00315.2002","volume":"284","author":"K Sharma","year":"2003","unstructured":"Sharma, K., McCue, P., & Dunn, S. R. (2003). Diabetic kidney disease in the db\/db mouse. American journal of physiology Renal Physiology, 284(6), F1138\u2013F1144.","journal-title":"American journal of physiology Renal Physiology"},{"issue":"4","key":"2631_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/joneph\/17.4.496","volume":"17","author":"AL Negri","year":"2004","unstructured":"Negri, A. L. (2004). Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. Journal of Nephrology, 17(4), 496\u2013503.","journal-title":"Journal of Nephrology"},{"issue":"9","key":"2631_CR18","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00467-008-0818-x","volume":"23","author":"M Zeisberg","year":"2008","unstructured":"Zeisberg, M., & Kalluri, R. (2008). Reversal of experimental renal fibrosis by BMP-7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatric Nephrology, 23(9), 1395\u20131398.","journal-title":"Pediatric Nephrology"},{"key":"2631_CR19","unstructured":"Lippincott's Illustrated Pharmacology Review. 1997: p. 232."},{"key":"2631_CR20","doi-asserted-by":"crossref","unstructured":"Cai, C., L. Hou, J. Zhang, D. Zhao, Z. Wang, H. Hu, J. He, W. Guan, and Y. Ma, (2017) The inhibitory effect of mesenchymal stem cells with rAd-NK4 on liver cancer. Applied Biochemistry and Biotechnology, p. 1\u201316.","DOI":"10.1007\/s12010-017-2456-x"},{"issue":"2","key":"2631_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12010-012-9958-3","volume":"169","author":"HT Wu","year":"2013","unstructured":"Wu, H. T., Sie, S. S., Kuan, T. C., & Lin, C. S. (2013). Identifying the regulative role of NF-\u03baB binding sites within promoter region of human matrix metalloproteinase 9 (mmp-9) by TNF-\u03b1 induction. Applied Biochemistry and Biotechnology, 169(2), 438\u2013449.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"3","key":"2631_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12010-015-1602-6","volume":"176","author":"HA Hassan","year":"2015","unstructured":"Hassan, H. A., & El-Gharib, N. E. (2015). Obesity and clinical riskiness relationship: therapeutic management by dietary antioxidant supplementation\u2014a review. Applied Biochemistry and Biotechnology, 176(3), 647\u2013669.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"2","key":"2631_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s12010-016-2342-y","volume":"182","author":"X Chen","year":"2017","unstructured":"Chen, X., & Xu, C. (2017). Proteomic analysis reveals the contribution of TGF\u03b2\/Smad4 signaling pathway to cell differentiation during planarian tail regeneration. Applied Biochemistry and Biotechnology, 182(2), 529\u2013545.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"11","key":"2631_CR24","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1681\/ASN.2006121318","volume":"18","author":"B Imberti","year":"2007","unstructured":"Imberti, B., Morigi, M., Tomasoni, S., Rota, C., Corna, D., Longaretti, L., Rottoli, D., Valsecchi, F., Benigni, A., & Wang, J. (2007). Insulin-like growth factor-1 sustains stem cell-mediated renal repair. Journal of the American Society of Nephrology, 18(11), 2921\u20132928.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"2631_CR25","doi-asserted-by":"publisher","first-page":"F1288","DOI":"10.1152\/ajprenal.00671.2009","volume":"299","author":"N Eliopoulos","year":"2010","unstructured":"Eliopoulos, N., Zhao, J., Bouchentouf, M., Forner, K., Birman, E., Yuan, S., Boivin, M.-N., & Martineau, D. (2010). Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. American Journal of Physiology-Renal Physiology, 299(6), F1288\u2013F1298.","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"46","key":"2631_CR26","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","volume":"103","author":"RH Lee","year":"2006","unstructured":"Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., & Prockop, D. J. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice. Proceedings of the National Academy of Sciences, 103(46), 17438\u201317443.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"2631_CR27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbmt.2008.01.006","volume":"14","author":"FE Ezquer","year":"2008","unstructured":"Ezquer, F. E., Ezquer, M. E., Parrau, D. B., Carpio, D., Ya\u00f1ez, A. J., & Conget, P. A. (2008). Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biology of Blood and Marrow Transplantation, 14(6), 631\u2013640.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"11","key":"2631_CR28","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.bbmt.2009.07.022","volume":"15","author":"F Ezquer","year":"2009","unstructured":"Ezquer, F., Ezquer, M., Simon, V., Pardo, F., Ya\u00f1ez, A., Carpio, D., & Conget, P. (2009). Endovenous administration of bone marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biology of Blood and Marrow Transplantation, 15(11), 1354\u20131365.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"4","key":"2631_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1089\/scd.2004.13.436","volume":"13","author":"A Alhadlaq","year":"2004","unstructured":"Alhadlaq, A., & Mao, J. J. (2004). Mesenchymal stem cells: isolation and therapeutics. Stem Cells and Development, 13(4), 436\u2013448.","journal-title":"Stem Cells and Development"},{"issue":"5","key":"2631_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s12010-016-2137-1","volume":"180","author":"P Jiang","year":"2016","unstructured":"Jiang, P., Dong, Z., Ma, B., Ni, Z., Duan, H., Li, X., Wang, B., Ma, X., Wei, Q., & Ji, X. (2016). Effect of vanadyl rosiglitazone, a new insulin-mimetic vanadium complexes, on glucose homeostasis of diabetic mice. Applied Biochemistry and Biotechnology, 180(5), 841\u2013851.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"3","key":"2631_CR31","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.1016\/0002-9149(93)90239-9","volume":"71","author":"CG Brilla","year":"1993","unstructured":"Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1993). Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. The American Journal of Cardiology, 71(3), A12\u2013A16.","journal-title":"The American Journal of Cardiology"},{"issue":"12","key":"2631_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.clinbiochem.2007.04.017","volume":"40","author":"MA Aziz","year":"2007","unstructured":"Aziz, M. A., Atta, H., Mahfouz, S., Fouad, H., Roshdy, N., Ahmed, H., Rashed, L., Sabry, D., Hassouna, A., & Hasan, N. (2007). Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clinical Biochemistry, 40(12), 893\u2013899.","journal-title":"Clinical Biochemistry"},{"issue":"4","key":"2631_CR33","first-page":"625","volume":"6","author":"MA Aziz","year":"2010","unstructured":"Aziz, M. A., Atta, H., Roshdy, N. K., Ahmed, H. H., Rashed, L. A., Obaia, E., Sabry, D., & Ahmed, A. (2010). Role of SDF-1\/CXCR4 axis in stem cell homing in the mouse model of induced lung fibrosis. International Journal Biotechnology Biochemistry, 6(4), 625\u2013644.","journal-title":"International Journal Biotechnology Biochemistry"},{"issue":"2","key":"2631_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95(2), 334\u2013340.","journal-title":"Analytical Biochemistry"},{"key":"2631_CR35","first-page":"882","volume":"61","author":"E Beutler","year":"1963","unstructured":"Beutler, E., Duron, O., & Kelly, B. M. (1963). Improved method for the determination of blood glutathione. The Journal of Laboratory and Clinical Medicine, 61, 882\u2013888.","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"key":"2631_CR36","doi-asserted-by":"crossref","unstructured":"Mortezaee, K., N. Khanlarkhani, F. Sabbaghziarani, S. Nekoonam, J. Majidpoor, A. Hosseini, P. Pasbakhsh, I.R. Kashani, and A. Zendedel, (2017). Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4. Cell and Tissue Research, p. 1\u201310.","DOI":"10.1007\/s00441-017-2604-1"},{"issue":"2","key":"2631_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3892\/ijmm.2014.1782","volume":"34","author":"X Yi","year":"2014","unstructured":"Yi, X., Li, X., Zhou, Y., Ren, S., Wan, W., Feng, G., & Jiang, X. (2014). Hepatocyte growth factor regulates the TGF-\u03b21-induced proliferation, differentiation and secretory function of cardiac fibroblasts. International Journal of Molecular Medicine, 34(2), 381\u2013390.","journal-title":"International Journal of Molecular Medicine"},{"key":"2631_CR38","first-page":"27","volume-title":"Histological Techniques","author":"RA Dury","year":"1980","unstructured":"Dury, R. A., & A.E. W. (1980). Histological Techniques (5th ed.pp. 27\u201329). Oxford: N. Y., Toronto.","edition":"5"},{"issue":"2","key":"2631_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ki.5000054","volume":"69","author":"Y Liu","year":"2006","unstructured":"Liu, Y. (2006). Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney International, 69(2), 213\u2013217.","journal-title":"Kidney International"},{"issue":"2","key":"2631_CR40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1523-1755.2005.67106.x","volume":"67","author":"GK Rangan","year":"2005","unstructured":"Rangan, G. K., Pippin, J. W., Coombes, J. D., & Couser, W. G. (2005). C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria. Kidney International, 67(2), 492\u2013503.","journal-title":"Kidney International"},{"issue":"5","key":"2631_CR41","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1111\/j.1523-1755.2004.00957.x","volume":"66","author":"GK Rangan","year":"2004","unstructured":"Rangan, G. K., Pippin, J. W., & Couser, W. G. (2004). C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney International, 66(5), 1838\u20131848.","journal-title":"Kidney International"},{"issue":"3","key":"2631_CR42","doi-asserted-by":"publisher","first-page":"F496","DOI":"10.1152\/ajprenal.90443.2008","volume":"296","author":"H Pan","year":"2009","unstructured":"Pan, H., Shen, Z., Mukhopadhyay, P., Wang, H., Pacher, P., Qin, X., & Gao, B. (2009). Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity. American journal of physiology Renal Physiology, 296(3), F496\u2013F504.","journal-title":"American journal of physiology Renal Physiology"},{"issue":"2","key":"2631_CR43","first-page":"83","volume":"3","author":"RH Shalaby","year":"2014","unstructured":"Shalaby, R. H., Rashed, L. A., Ismaail, A. E., Madkour, N. K., & Elwakeel, S. H. (2014). Hematopoietic stem cells derived from human umbilical cord ameliorate cisplatin-induced acute renal failure in rats. American journal of stem cells, 3(2), 83\u201396.","journal-title":"American journal of stem cells"},{"key":"2631_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2015.10.010","volume":"77","author":"NM Elsherbiny","year":"2016","unstructured":"Elsherbiny, N. M., Eladl, M. A., & Al-Gayyar, M. M. (2016). Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model. Cytokine, 77, 26\u201334.","journal-title":"Cytokine"},{"issue":"4","key":"2631_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1684\/ecn.2014.0344","volume":"24","author":"HS Bayomi","year":"2013","unstructured":"Bayomi, H. S., Elsherbiny, N. M., El-Gayar, A. M., & Al-Gayyar, M. M. (2013). Evaluation of renal protective effects of inhibiting TGF-beta type I receptor in a cisplatin-induced nephrotoxicity model. European Cytokine Network, 24(4), 139\u2013147.","journal-title":"European Cytokine Network"},{"issue":"6","key":"2631_CR46","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence, T. (2009). The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology, 1(6), a001651.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"3","key":"2631_CR47","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s12010-015-1608-0","volume":"176","author":"N Raju","year":"2015","unstructured":"Raju, N., Sakthivel, K. M., Kannan, N., Prabhu, V. V., & Guruvayoorappan, C. (2015). Cuscuta chinensis ameliorates immunosuppression and urotoxic effect of cyclophosphamide by regulating cytokines-GM-CSF and TNF-alpha. Applied Biochemistry and Biotechnology, 176(3), 742\u2013757.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"12","key":"2631_CR48","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/ki.2008.409","volume":"74","author":"MJ Sung","year":"2008","unstructured":"Sung, M. J., Kim, D. H., Jung, Y. J., Kang, K. P., Lee, A. S., Lee, S., Kim, W., Davaatseren, M., Hwang, J. T., Kim, H. J., Kim, M. S., Kwon, D. Y., & Park, S. K. (2008). Genistein protects the kidney from cisplatin-induced injury. Kidney International, 74(12), 1538\u20131547.","journal-title":"Kidney International"},{"issue":"1","key":"2631_CR49","doi-asserted-by":"publisher","first-page":"F325","DOI":"10.1152\/ajprenal.00158.2007","volume":"293","author":"G Ramesh","year":"2007","unstructured":"Ramesh, G., Zhang, B., Uematsu, S., Akira, S., & Reeves, W. B. (2007). Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice. American Journal of Physiology Renal Physiology, 293(1), F325\u2013F332.","journal-title":"American Journal of Physiology Renal Physiology"},{"issue":"2","key":"2631_CR50","doi-asserted-by":"publisher","first-page":"F812","DOI":"10.1152\/ajprenal.00277.2006","volume":"292","author":"G Ramesh","year":"2007","unstructured":"Ramesh, G., Kimball, S. R., Jefferson, L. S., & Reeves, W. B. (2007). Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells. American Journal of Physiology Renal Physiology, 292(2), F812\u2013F819.","journal-title":"American Journal of Physiology Renal Physiology"},{"issue":"10","key":"2631_CR51","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3109\/10408444.2011.602662","volume":"41","author":"PD Sanchez-Gonzalez","year":"2011","unstructured":"Sanchez-Gonzalez, P. D., Lopez-Hernandez, F. J., Lopez-Novoa, J. M., & Morales, A. I. (2011). An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Critical Reviews in Toxicology, 41(10), 803\u2013821.","journal-title":"Critical Reviews in Toxicology"},{"issue":"12","key":"2631_CR52","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1093\/ndt\/gfm393","volume":"22","author":"P Boor","year":"2007","unstructured":"Boor, P., Sebekova, K., Ostendorf, T., & Floege, J. (2007). Treatment targets in renal fibrosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22(12), 3391\u20133407.","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"issue":"1","key":"2631_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ki.1995.265","volume":"48","author":"SM Feld","year":"1995","unstructured":"Feld, S. M., Hirschberg, R., Artishevsky, A., Nast, C., & Adler, S. G. (1995). Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney International, 48(1), 45\u201351.","journal-title":"Kidney International"},{"issue":"6","key":"2631_CR54","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/ki.1997.479","volume":"52","author":"DW Johnson","year":"1997","unstructured":"Johnson, D. W., Saunders, H. J., Brew, B. K., Ganesan, A., Baxter, R. C., Poronnik, P., Cook, D. I., Gyory, A. Z., Field, M. J., & Pollock, C. A. (1997). Human renal fibroblasts modulate proximal tubule cell growth and transport via the IGF-I axis. Kidney International, 52(6), 1486\u20131496.","journal-title":"Kidney International"},{"issue":"1","key":"2631_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1046\/j.1523-1755.2001.00776.x","volume":"60","author":"S Wang","year":"2001","unstructured":"Wang, S., Denichilo, M., Brubaker, C., & Hirschberg, R. (2001). Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney International, 60(1), 96\u2013105.","journal-title":"Kidney International"},{"issue":"3","key":"2631_CR56","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1083\/jcb.121.3.679","volume":"121","author":"JI Jones","year":"1993","unstructured":"Jones, J. I., Gockerman, A., Busby Jr., W. H., Camacho-Hubner, C., & Clemmons, D. R. (1993). Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. The Journal of Cell Biology, 121(3), 679\u2013687.","journal-title":"The Journal of Cell Biology"},{"issue":"3","key":"2631_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0016-5085(97)70176-8","volume":"113","author":"JF Kuemmerle","year":"1997","unstructured":"Kuemmerle, J. F. (1997). Autocrine regulation of growth in cultured human intestinal muscle by growth factors. Gastroenterology, 113(3), 817\u2013824.","journal-title":"Gastroenterology"},{"issue":"4 Pt 1","key":"2631_CR58","first-page":"G875","volume":"273","author":"EM Zimmermann","year":"1997","unstructured":"Zimmermann, E. M., Li, L., Hou, Y. T., Cannon, M., Christman, G. M., & Bitar, K. N. (1997). IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. The American Journal of Physiology, 273(4 Pt 1), G875\u2013G882.","journal-title":"The American Journal of Physiology"},{"issue":"3","key":"2631_CR59","first-page":"541","volume":"137","author":"T Doi","year":"1990","unstructured":"Doi, T., Striker, L. J., Gibson, C. C., Agodoa, L. Y., Brinster, R. L., & Striker, G. E. (1990). Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. The American Journal of Pathology, 137(3), 541\u2013552.","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"2631_CR60","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1210\/endo-123-6-2827","volume":"123","author":"LS Mathews","year":"1988","unstructured":"Mathews, L. S., Hammer, R. E., Behringer, R. R., D'Ercole, A. J., Bell, G. I., Brinster, R. L., & Palmiter, R. D. (1988). Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology, 123(6), 2827\u20132833.","journal-title":"Endocrinology"},{"issue":"1","key":"2631_CR61","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1210\/endo-124-1-40","volume":"124","author":"CJ Quaife","year":"1989","unstructured":"Quaife, C. J., Mathews, L. S., Pinkert, C. A., Hammer, R. E., Brinster, R. L., & Palmiter, R. D. (1989). Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology, 124(1), 40\u201348.","journal-title":"Endocrinology"},{"issue":"3","key":"2631_CR62","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1006\/bbrc.1998.8676","volume":"246","author":"Y Liu","year":"1998","unstructured":"Liu, Y., Sun, A. M., & Dworkin, L. D. (1998). Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochemical and Biophysical Research Communications, 246(3), 821\u2013826.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"2631_CR63","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1046\/j.1523-1755.1998.00092.x","volume":"54","author":"Y Yo","year":"1998","unstructured":"Yo, Y., Morishita, R., Nakamura, S., Tomita, N., Yamamoto, K., Moriguchi, A., Matsumoto, K., Nakamura, T., Higaki, J., & Ogihara, T. (1998). Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney International, 54(4), 1128\u20131138.","journal-title":"Kidney International"},{"issue":"1","key":"2631_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00041552-200201000-00004","volume":"11","author":"Y Liu","year":"2002","unstructured":"Liu, Y. (2002). Hepatocyte growth factor and the kidney. Current Opinion in Nephrology and Hypertension, 11(1), 23\u201330.","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"6","key":"2631_CR65","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1046\/j.1523-1755.2001.00717.x","volume":"59","author":"K Matsumoto","year":"2001","unstructured":"Matsumoto, K., & Nakamura, T. (2001). Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney International, 59(6), 2023\u20132038.","journal-title":"Kidney International"},{"issue":"Suppl 16","key":"2631_CR66","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1093\/joneph\/23.S16.S136","volume":"23","author":"MC Hu","year":"2010","unstructured":"Hu, M. C., Kuro-o, M., & Moe, O. W. (2010). Klotho and kidney disease. Journal of Nephrology, 23(Suppl 16), S136\u2013S144.","journal-title":"Journal of Nephrology"},{"key":"2631_CR67","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.2741\/3389","volume":"14","author":"HW Schnaper","year":"2009","unstructured":"Schnaper, H. W., Jandeska, S., Runyan, C. E., Hubchak, S. C., Basu, R. K., Curley, J. F., Smith, R. D., & Hayashida, T. (2009). TGF-beta signal transduction in chronic kidney disease. Frontiers in Bioscience, 14, 2448\u20132465.","journal-title":"Frontiers in Bioscience"},{"issue":"8","key":"2631_CR68","doi-asserted-by":"publisher","first-page":"892","DOI":"10.7150\/ijbs.11729","volume":"11","author":"J Barrera-Chimal","year":"2015","unstructured":"Barrera-Chimal, J., Perez-Villalva, R., Ortega, J. A., Sanchez, A., Rodriguez-Romo, R., Durand, M., Jaisser, F., & Bobadilla, N. A. (2015). Mild ischemic injury leads to long-term alterations in the kidney: amelioration by spironolactone administration. International Journal of Biological Sciences, 11(8), 892\u2013900.","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"2631_CR69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.krcp.2011.12.005","volume":"31","author":"Y Oh","year":"2012","unstructured":"Oh, Y. (2012). The insulin-like growth factor system in chronic kidney disease: pathophysiology and therapeutic opportunities. Kidney Research and Clinical Practice, 31(1), 26\u201337.","journal-title":"Kidney Research and Clinical Practice"},{"issue":"3","key":"2631_CR70","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1634\/stemcells.2008-0496","volume":"27","author":"CS Alexandre","year":"2009","unstructured":"Alexandre, C. S., Volpini, R. A., Shimizu, M. H., Sanches, T. R., Semedo, P., Di Jura, V. L., Camara, N. O., Seguro, A. C., & Andrade, L. (2009). Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells, 27(3), 682\u2013692.","journal-title":"Stem Cells"},{"issue":"3","key":"2631_CR71","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/ndt\/17.3.363","volume":"17","author":"IL Noronha","year":"2002","unstructured":"Noronha, I. L., Fujihara, C. K., & Zatz, R. (2002). The inflammatory component in progressive renal disease\u2014are interventions possible? Nephrology Dialysis Transplantation, 17(3), 363\u2013368.","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"2631_CR72","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1046\/j.1523-1755.1998.00138.x","volume":"54","author":"CK Fujihara","year":"1998","unstructured":"Fujihara, C. K., Malheiros, D. M. A. C., Zatz, R., & de Lourdes Noronha, I. (1998). Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney International, 54(5), 1510\u20131519.","journal-title":"Kidney International"},{"issue":"6","key":"2631_CR73","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation, 119(6), 1420.","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"2631_CR74","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/ki.2008.425","volume":"75","author":"FM Strutz","year":"2009","unstructured":"Strutz, F. M. (2009). EMT and proteinuria as progression factors. Kidney International, 75(5), 475\u2013481.","journal-title":"Kidney International"},{"key":"2631_CR75","doi-asserted-by":"crossref","unstructured":"Humphreys, B.D. and J.V. Bonventre, (2008). Mesenchymal stem cells in acute kidney injury. Annual Review of Medicine. 59.","DOI":"10.1146\/annurev.med.59.061506.154239"},{"issue":"4","key":"2631_CR76","doi-asserted-by":"publisher","first-page":"R861","DOI":"10.1152\/ajpregu.00384.2005","volume":"290","author":"S Villanueva","year":"2006","unstructured":"Villanueva, S., C\u00e9spedes, C., & Vio, C. P. (2006). Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 290(4), R861\u2013R870.","journal-title":"American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"},{"issue":"5","key":"2631_CR77","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1111\/j.1523-1755.2005.00629.x","volume":"68","author":"JS Duffield","year":"2005","unstructured":"Duffield, J. S., & Bonventre, J. V. (2005). Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney International, 68(5), 1956\u20131961.","journal-title":"Kidney International"},{"issue":"12","key":"2631_CR78","first-page":"3810","volume":"117","author":"DF Higgins","year":"2007","unstructured":"Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., & Cohen, C. D. (2007). Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. The Journal of Clinical Investigation, 117(12), 3810.","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"2631_CR79","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1365-2443.2009.01303.x","volume":"14","author":"J Inumaru","year":"2009","unstructured":"Inumaru, J., Nagano, O., Takahashi, E., Ishimoto, T., Nakamura, S., Suzuki, Y., Niwa, S. I., Umezawa, K., Tanihara, H., & Saya, H. (2009). Molecular mechanisms regulating dissociation of cell\u2013cell junction of epithelial cells by oxidative stress. Genes to Cells, 14(6), 703\u2013716.","journal-title":"Genes to Cells"}],"updated-by":[{"DOI":"10.1007\/s12010-026-05651-8","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000}}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-017-2631-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-017-2631-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-017-2631-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:01:52Z","timestamp":1774652512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-017-2631-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["2631"],"URL":"https:\/\/doi.org\/10.1007\/s12010-017-2631-0","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,17]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12010-026-05651-8","URL":"https:\/\/doi.org\/10.1007\/s12010-026-05651-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there is no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}